Replies to post #122084 on Biotech Values

[DewDiligence]

…Humira [is] expected to be the biggest-selling medicine in 2012 with sales of $8.7bn. Humira is forecast to grow 5% annually to reach $9.7bn by 2016, almost $2bn higher than its nearest challenger, Roche's Avastin…

Source: EvaluatePharma (http://finance.yahoo.com/news/Humira-to-Assume-Lipitors-prnews-3889390601.html?x=0&.v=2 )